Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Are ICD-10 codes appropriate for performance assessment in asthma and COPD in general practice? Results of a cross sectional observational study

  • Antonius Schneider1Email author,
  • Lutz Gantner1,
  • Inko Maag1,
  • Mathias M Borst2,
  • Michel Wensing1 and
  • Joachim Szecsenyi1
BMC Health Services Research20055:11

DOI: 10.1186/1472-6963-5-11

Received: 16 July 2004

Accepted: 01 February 2005

Published: 01 February 2005

Abstract

Background

The increasing prevalence and impact of obstructive lung diseases and new insights, reflected in clinical guidelines, have led to concerns about the diagnosis and therapy of asthma and COPD in primary care. In Germany diagnoses written in medical records are used for reimbursement, which may influence physicians' documentation behaviour. For that reason it is unclear to what respect ICD-10 codes reflect the real problems of the patients in general practice. The aim of this study was to assess the appropriateness of the recorded diagnoses and to determine what diagnostic information is used to guide medical treatment.

Methods

All patients with lower airway symptoms (n = 857) who had attended six general practices between January and June 2003 were included into this cross sectional observational study. Patients were selected from the computerised medical record systems, focusing on ICD-10-codes concerning lower airway diseases (J20-J22, J40-J47, J98 and R05). The performed diagnostic procedures and actual medication for each identified patient were extracted manually. Then we examined the associations between recorded diagnoses, diagnostic procedures and prescribed treatment for asthma and COPD in general practice.

Results

Spirometry was used in 30% of the patients with a recorded diagnosis of asthma and in 58% of the patients with a recorded diagnosis of COPD. Logistic regression analysis showed an improved use of spirometry when inhaled corticosteroids were prescribed for asthma (OR = 5.2; CI 2.9–9.2) or COPD (OR = 4.7; CI 2.0–10.6). Spirometry was also used more often when sympathomimetics were prescribed (asthma: OR = 2.3; CI 1.2–4.2; COPD: OR = 4.1; CI 1.8–9.4).

Conclusions

This study revealed that spirometry was used more often when corticosteroids or sympathomimetics were prescribed. The findings suggest that treatment was based on diagnostic test results rather than on recorded diagnoses. The documented ICD-10 codes may not always reflect the real status of the patients. Thus medical care for asthma and COPD in general practice may be better than initially found on the basis of recorded diagnoses, although further improvement of practice patterns in asthma and COPD is still necessary.

Background

There is broad agreement between existing guidelines for asthma [14] regarding diagnostic procedures, patient education and medical treatment [5]. The statements for chronic obstructive pulmonary disease (COPD) [68] are also consistent, despite the lack of evidence for some recommendations [9]. However, it has been shown previously that the management of these diseases in practice was not fully consistent with the guidelines [1012], which may be related to the variety of views on the treatment of these conditions [13, 14]. Furthermore, the knowledge about the diseases is changing rapidly and the management has become more complex [15, 16]. Many patients with asthma or COPD are managed in primary care and it is important to optimise the treatment given the prevalence and impact [17].

However, it remains difficult to draw a clear picture of management of obstructive lung diseases in primary care since the diagnoses of asthma and COPD often have not been separated in many surveys [7]. This could be due to some diagnostic and therapeutic overlap between these both diseases. Especially in primary care it is difficult to distinguish both entities when the symptoms are presented in an early stage [18]. In particular the treatment response in this stage often seem to be not strongly related to the stated diagnoses [19, 20], and also the treatment response of COPD in the long term course is disappointing [21].

Furthermore, systematic registration of diseases in primary care are often hampered by missing of recorded diagnoses [22] or discrepancies between diagnoses and prescribed medications [23]. A specific problem for health services research and performance assessment in Germany might be that diagnoses saved in medical records are used for reimbursement. For that reason it is unclear to what respect ICD-10 codes reflect the real problems of patients in general practice. It may be possible that physicians enter diagnoses in their records to get reimbursement, but use other information such as results of diagnostic tests for treatment. Empirical evidence on this phenomenon is limited, but its existence would complicate the assessment of practice patterns.

The aim of this study was to assess the appropriateness of the recorded diagnoses and to determine what diagnostic information is used to guide medical treatment. For this purpose we analysed associations between recorded diagnoses, diagnostic procedures and medical treatment regarding asthma and COPD in general practice.

Methods

Study design

A cross-sectional observational study was performed in six computerised general practices with a total of eleven GPs in the Rhine-Neckar region in Southern Germany.

Setting and study subjects

All patients who had attended their physicians with asthma, COPD or other lower airway diseases from January until June 2003 were included in the study.

Ethical approval

The study was approved by the Medical Ethics Committee of the University of Heidelberg.

Procedure for selection of subjects

Patients were identified by searching the electronic files for documented diagnoses concerning lower airway diseases within the time frame. The data were evaluated systematically according to the international classification of diseases (ICD-10). In detail, the practice software was checked for the ICD-10-codes of the chapter "chronic lower airway disease": J40 (bronchitis, not specified as acute or chronic), J41 (simple and mucopurulent chronic bronchitis), J42 (unspecified chronic bronchitis), J43 (emphysema), J44 (chronic obstructive pulmonary disease), J45 (asthma), J46 (status asthmaticus), J47 (bronchiectasis). Additionally, the ICD-10-codes J98 (diseases of bronchus, not elsewhere classified) and R05 (cough / bronchial hyperreactivity), and the repeated documentation of ICD-10-codes belonging to the chapter "acute lower airway disease" were extracted in order to detect potentially existing but not detected asthma or COPD. The chapter "acute lower airway disease" includes the diagnoses J20 (acute bronchitis), J21 (acute bronchiolitis) and J22 (unspecified acute lower respiratory infection).

The performed diagnostic procedures and the actual medication for each identified patient were extracted and documented manually by two independent scientific fellows (L.G., I.M.) of the department. The variables of the used protocol for documentation are listed in table 2.
Table 1

Baseline characteristics

 

Overall (n = 857)

Asthma (n = 255)

COPD (n = 112)

Asthma + COPD (n = 25)

Other (n = 465)

age

41.84 ± 22.18

(min 1; max 97)

36.48 + 21.00

(min 1; max 88)

56.28 + 18.38

(min 21; max 92)

46.23 + 19.16

(min 26; max 71)

41.06 + 22.32

(min 1; max 97)

sex

m 385; f 472

m 121; f 134

m 55; f 57

m 15; f 10

m 194; f 271

Analysis

Every ICD10-code specified above was extracted and written down, at maximum up to three ICD-10-Codes per patient were found. The diagnoses were clustered into three groups: asthma, COPD, and other lower airway diseases. If more than one diagnosis was documented, asthma (J45) or COPD (J44) were extracted as the leading diagnosis.

The ICD-10 group J43 (emphysema) was included into the ICD-10 group J 44 (COPD). The ICD-10 groups other than J45 (asthma), J44 or J43 were merged into the group "other lower airway diseases".

The performed diagnostic procedures were extracted manually. Four ways of making diagnoses have been found in the records: 1. taking medical history only, 2. taking medical history plus trial of medication, 3. taking medical history and performing spirometry, 4. taking medical history plus single measurement of PEF. The additional performance of bronchial challenge testing and chest X-ray was documented, too.

Baseline data were evaluated descriptively. The t-test was used to detect differences of age. Linear logistic regression was used to test relationships between diagnosing asthma or COPD and the performed diagnostics. The relation between prescribing patterns and performed diagnostics was also examined with logistic regression analysis.

Results

Overall, 8765 patients attended the practices within the time frame. 857 (9,8%) patients had lower airways diseases (385 male, 472 female).

A total of 255 (2.9% of 8765) had the recorded diagnosis of asthma and 112 (1.3% of 8765) had COPD (107 with J44 = COPD, 5 with J43 = emphysema). A combination of asthma and COPD was documented in 25 (0.2% of 8765) cases.

The 465 (5.3% of 8765) patients with "other lower airway diseases" included seven cases with acute bronchitis (J20), none with acute bronchiolitis (J21), one case with unspecified acute lower respiratory infection (J22), 251 (2.9% of 8765) cases with not specified bronchitis (J40), 38 with simple and mucopurulent chronic bronchitis (J41), 57 with unspecific chronic bronchitis (J42), one with bronchiectasis (J47), seven with diseases of bronchus, not classified (J98), 103 (1.2% of 8765) with cough / bronchial hyperreactivity (R05), Patients with COPD were significantly older than those with asthma or other lower airway diseases. There was no case of twofold documentation of "acute lower airway disease" (J20 - J22) within the time frame. The details regarding the patient population are described in table 1.
Table 2

Performed diagnostics and documented diagnoses

 

Asthma (n = 255)

COPD (n = 112)

Other (n = 465)

Performed diagnostics

n

%

OR

95% CI

n

%

OR

95% CI

n

%

OR

95% CI

Medical history only

42

16.5

0.11

0.07–0.15

33

29.3

0.31

0.20–0.46

338

72.7

10.9

7.89–15.02

Medical history and trial of medication

57

22.4

8.11

4.68–14.08

6

5.4

0.51

0.23–1.13

12

2.6

0.14

0.07–0.26

Medical history and spirometry

77

30.2

1.30

0.99–1.72

65

58.1

4.38

2.99–6.40

90

19.4

0.37

0.27–0.50

Medical history and PEF-measurement

79

31.0

7.57

4.93–11.60

8

7.1

0.81

0.47–1.40

25

5.4

0.18

0.11–0.28

Additional bronchial challenge test

18

3.9

1.35

0.73–2.48

24

21.4

6.74

3.66–12.42

1

0

0.16

0.08–0.35

Additional chest X-ray

34

13.3

0.88

0.58–1.31

42

37.5

4.06

2.67–6.19

48

10.3

0.44

0.30–0.65

Diagnostics

Table 2 shows the performed diagnostic procedures. Spirometry was performed in 30% of the patients with recorded asthma. A high amount was diagnosed with 'medical history and single measurement of peak expiratory flow' (31%), and 22% of cases fell into the category of medical history taking plus trial of medication (= diagnosing by therapy). This implies that the physician gives sympathomimetics in suspected asthma. If the patient feels better, the diagnosis 'asthma' is made.

In about 17% the diagnosis asthma was made only on the basis of medical history

Spirometry was performed in 58% of the cases with recorded COPD. In 29% the diagnosis was made only by medical history. A small percentage (7%) was diagnosed by history taking and PEF-measurement and 5% by diagnosing by therapy.

Concerning the other lower airway diseases, spirometry was done in 19% in order to exclude asthma or COPD. These diagnoses were made mainly on the basis of medical history (73%).

The associations between recorded diagnoses and diagnostic procedures are calculated by binary logistic regression (also in table 2). The higher the odds ratio (OR) the higher is the positive association between the variables. Patients with the combined diagnosis of asthma and COPD were not included into the analysis. An odds ratio smaller than one means that there is a negative association between those variables. Significant results are bold.

The logistic regression showed that the diagnosis asthma was often based only on single measurement of PEF (OR 7.6) or 'trial of medication' (OR 8.1). The use of spirometry was not significantly associated with the recorded diagnosis asthma.

Concerning the recorded diagnosis of COPD, 'trial of medication' was not associated significantly. Instead, the recorded diagnosis was based on spirometry (OR 4.4). Bronchial challenge testing was used to exclude asthma (OR 6.7). Also chest X-ray showed a significant association with the recorded diagnosis of COPD (OR 4.1).

The recording of other lower airway diseases was mainly based on the medical history (OR 10.9), the other diagnostic procedures are used only in few cases (OR < 1).

Prescriptions

The documentation of the prescribed medication showed that 66% of patients with asthma and 42% with COPD received sympathomimetics (table 3). 38% of the asthma patients received inhaled corticosteroids, whereas 46% of the patients with COPD were treated with inhaled corticosteroids. Cromoglycate was given in 36% of patients with asthma and 14% of COPD.
Table 3

Relationship between performed diagnostis. actual treatment and documented diagnoses

Performed diagnostics and actual treatment

Asthma (n = 255)

COPD (n = 112)

Other (n = 465)

 

n

%

OR

95% CI

n

%

OR

95% CI

n

%

OR

95% CI

Sympathomimetics

(n = 167; 65.5%)

(n = 47; 42.0%)

(n = 36; 7.7%)

Medical history only

9

3.5

0.22

0.10–0.51

7

6.3

1.35

0.56–3.26

10

2.2

4.97

2.05–12.02

Medical history and trial of medication

52

20.4

7.99

3.06–20.85

4

3.6

2.93

0.51–16.71

8

1.7

31.48

8.95–111.2

Medical history and spirometry

60

23.5

2.28

1.24–4.18

36

32.1

4.06

1.77–9.35

14

3.0

3.10

1.51–6.36

Medical history and PEF-measurement

46

18.0

0.67

0.43–1.07

0

0

0

0-0

4

1.0

2.39

0.77–7.36

Additional bronchial challenge test

12

4.7

3.51

0.77–16.04

9

8.0

1.16

0.44–3.08

0

0

0.01

0–109

Additional chest X-ray

22

8.6

1.02

0.48–2.17

22

19.6

1.98

0.91–4.31

6

1.0

1.91

0.75–4.86

Corticosteroids

(n = 96; 37.6%)

(n = 52; 46.4%)

(n = 28; 6.0%)

Medical history only

4

1.6

0.23

0.08–0.66

9

8.0

2.22

0.85–5.78

5

1.0

2.37

0.78–7.23

Medical history and trial of medication

20

7.8

0.91

0.49–1.68

3

2.7

1.16

0.22–6.03

5

1.05

13.99

4.11–47.64

Medical history and spirometry

49

19.2

5.17

2.91–9.19

40

35.7

4.67

2.05–10.64

15

3.2

6.05

2.72–13.45

Medical history and PEF-measurement

23

9.0

0.58

0.33–1.02

0

0

0

0–14 × 104

3

1.0

2.26

0.63–8.04

Additional bronchial challenge test

9

3.5

3.30

1.07–10.17

16

14.3

6.22

1.93–20.11

0

0

0.00

0-0

Additional chest X-ray

16

6.3

1.63

0.79–3.37

29

25.9

4.56

2.00–10.38

10

2.2

6.19

2.65–14.47

Cromoglycate

(n = 91; 35.7%)

(n = 16; 14.3%)

(n = 39; 8.4%)

Medical history only

9

3.5

0.16

0.07–0.37

1

1.0

0.23

0.05–1.02

21

4.5

12.02

4.93–29.29

Medical history and trial of medication

24

9.4

1.52

0.83–2.79

0

0

0.00

0–1.6 × 1018

4

1.0

6.16

1.77–21.51

Medical history and spirometry

23

9.0

0.74

0.42–1.32

10

8.9

1.07

0.40–2.86

10

2.2

1.70

0.89–3.25

Medical history and PEF-measurement

35

13.7

1.74

1.01–3.00

5

4.5

14.1

2.96–67.18

4

1.0

2.17

0.71–6.65

Additional bronchial challenge test

5

2.0

1.06

0.34–3.26

4

3.6

1.67

0.48–5.83

1

0

1.62

0.19–13.54

Additional chest X-ray

9

3.5

0.65

0.29–1.46

5

4.5

0.73

0.23–2.25

8

1.7

2.58

1.11–6.01

Only a small amount of patients with 'other lower airway diseases' received anti-obstructive medicine (6–8%).

The logistic regression showed that sympathomimetics were given in asthma when having shown efficacy (trial of medication) (OR 8.0) or when spirometry was performed (OR 2.3). Therapy with corticosteroids was significantly associated with spirometry (OR 5.2) and bronchial challenge testing (OR 3.3).

Treatment of COPD with sympathomimetics was significantly associated with the use of spirometry (OR 4.1). Inhaled corticosteroids were also given more often when spirometry (OR 4.7) and Chest X-ray (OR 4.6) had been performed. Bronchial challenge testing was used to exclude asthma (OR 6.2).

In asthma as well as in COPD corticosteroids are not prescribed only by trial of medication and are not given after making the diagnosis only by medical history.

Prescribing of cromoglycate was associated with PEF measurement in both asthma and COPD (OR 1.7 respectively 14.1)

Treatment of the other lower airway diseases with sympathomimetics respectively corticosteroids was mainly associated with testing the efficacy of therapy (OR 31.5 respectively 14.0). The prescription is lower associated with spirometry (OR 3.1 respectively 6.1) or x-ray (OR 1.9 respectively 6.2). Cromoglycates were given mostly on the basis of 'taking medical history only' (OR 12.0) and trial of medication (OR 6.2).

Discussion

Although guidelines recommend the use of spirometry, this was used in only in 30% of the patients with a recorded diagnosis of asthma and in 58% of the patients with a recorded diagnosis of COPD. A high number of recorded diagnoses of asthma and COPD were insufficiently diagnosed by PEF-measurement, medical history and diagnosing by therapy. On the first sight, patients with asthma seem to be treated insufficiently with anti-inflammatory therapy and patients with COPD seemed to be over-treated with steroids.

However, further analysis showed a high association between prescribed corticosteroids and sympathomimetics as long term medication and performed diagnostic procedures. This improvement of diagnostic investigation when potential harmful drugs are given demonstrates that treatment of asthma and COPD by the GPs may be more consistent with guidelines than other studies have found [10, 13]. This hypothesis is facilitated by the fact, that cromoglycates seem to be administered if there was diagnostic uncertainty, as there was no significant association between performing spirometry and making diagnoses in those cases.

According to this, our study shows that a deeper look insight with analysis of diagnoses together with performed diagnostics and medication could prove a better care for people with obstructive airway diseases than a single analysis of the documented diagnoses. As a conclusion, ICD-10 codes seem not to be able to reflect the work in primary care, in particular if the difficulties of the diagnostic and therapeutic differentiation between asthma and COPD in earlier stages are taken into account [18, 20].

Therefore it seems that the documented diagnosis due to ICD-10 often serves as a 'working hypothesis'. The needs of family physicians for practice and research would be best met by the International Classification of Primary Care (ICPC-2) [24], but the general practitioners in Germany are politically obliged to record ICD-10 diagnoses to get reimbursement. As the documentation of the reason of encounter is restricted in these terms of ICD-codes there could be some necessity to assign diagnoses although they do not match with the real status of the patient. This makes the recorded diagnoses unreliable, sometimes resulting in apparently poor coherence between medication and diagnoses, and this leads to difficulties in drawing valid conclusions on the quality of primary care.

Another critical point is, that the 'trial of medication' as a 'fact of life in primary care' could implicate a patients' perception of improvement which could lead the doctor to perpetuate the therapy, thus resulting in over-prescribing accompanied by an avoidable risk of side-effects. Especially this 'trial of medication' may reflect diagnostic uncertainty in general practice, which must normally have consequences for the classification and labelling. In absence of a reasonable classification system the GPs are forced to hide this uncertainty by documenting diagnoses in ICD-10-codes. As a result, GPs could feel the uncertainty nevertheless, but start seeing it as a personal shortcoming rather than a reality of medicine. Therefore this exaggeration of 'labelling with ICD-10' could also constrain a systematic quality improvement in diagnostic performance in primary care.

The strength of the study was the detailed analysis with manual extraction and documentation of performed diagnostics and actual medication of each identified patient. As the ICD-10 classification made it difficult to identify patients with obstructive airway diseases in junction with performed diagnostics and therapy we searched all records manually. Because of this complexity the study had the limitation that the number of GPs was small, which reduces the generalisability of the descriptive findings, although the estimates of associations are less sensitive for this problem.

The prevalence of asthma and COPD in this German sample of general practice seems to be low compared to the prevalence of about 5% in studies of other countries [2527]. One explanation might be the high doctor-patient contact rate in Germany that decreases the prevalence of severe diseases in general practice.

Conclusions

The conclusion of this study is that performance assessment should take the reliability problems of recorded diagnoses into account, especially if the ICD-10 classification is used. A more detailed analysis may be necessary for adequate evaluation of primary care, consequential pointing out to the fact, that treatment of obstructive airways diseases by the GP's may be more consistent with guidelines than other studies have found. Despite these findings improvement of diagnostic performance in general practice is necessary, because a routine use of spirometry is of growing importance against the background of the increasing prevalence of obstructive airway diseases.

Authors contributions

AS conceived and designed the study, wrote the report. LG and IM checked the practice software and documented data. MB helped with interpreting the data and writing the report. MW helped with interpreting the data and writing the report. JS helped with revising the report. All authors read and approved the final manuscript.

Declarations

Acknowledgements

We are grateful to the general practitioners, namely Jörg Barlet, Stefan Bilger, Vera Datzer, Richard Michel, Berthold Musselmann and Andreas Wichmann for collaborating in this study.

And we are indebted to the reviewer for his very helpful comments to improve this manuscript, thus leading to a higher precision in presentation and discussion of our findings.

Authors’ Affiliations

(1)
Department of General Practice and Health Services Research
(2)
Caritas Medical Hospital I

References

  1. Society BT: British Guideline for the Management of Asthma. Thorax. 2003, 58: S1-S94.View ArticleGoogle Scholar
  2. Association CM: Canadian asthma consensus report, 1999. Canadian Medical Association Journal. 1999, 161: S1-S62.Google Scholar
  3. Council NA: Asthma Management Handbook 2002. 2002, South Melbourne 3205Google Scholar
  4. Health NI: Global Initiative for Asthma - Global Strategy for Asthma Management and Prevention. Edited by: National Heart LBI. 2002, www.ginasthma.comGoogle Scholar
  5. Schneider A, Borst MM, Gerlach FM, Szecsenyi J: Suspected Diagnosis of Bronchial Asthma - Development of an Algorithm for the Diagnosis of Asthma in General Practice. Z Arztl Fortbild Qualitatssich. 2003, 97: 485-493.PubMedGoogle Scholar
  6. Society BT: BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax. 1997, 52 Suppl 5: S1-28.Google Scholar
  7. Health NI: Global Initiative for Chronic Obstructive Lung Disease (GOLD). Edited by: National Heart LBI. 2003, www.goldcopd.comGoogle Scholar
  8. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, .: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995, 8: 1398-1420. 10.1183/09031936.95.08081398.View ArticlePubMedGoogle Scholar
  9. Ferguson GT: Recommendations for the management of COPD. Chest. 2000, 117: 23S-28S. 10.1378/chest.117.2_suppl.23S.View ArticlePubMedGoogle Scholar
  10. Montnemery P, Hansson L, Lanke J, Lindholm LH, Nyberg P, Lofdahl CG, Adelroth E: Accuracy of a first diagnosis of asthma in primary health care. Fam Pract. 2002, 19: 365-368. 10.1093/fampra/19.4.365.View ArticlePubMedGoogle Scholar
  11. Rabe KF, Vermeire PA, Soriano JB, Maier WC: Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000, 16: 802-807. 10.1183/09031936.00.16580200.View ArticlePubMedGoogle Scholar
  12. Voelkel NF: Raising awareness of COPD in primary care. Chest. 2000, 117: 372S-375S. 10.1378/chest.117.5_suppl_2.372S.View ArticlePubMedGoogle Scholar
  13. Lagerlov P, Veninga CC, Muskova M, Hummers-Pradier E, Stalsby LC, Andrew M, Haaijer-Ruskamp FM: Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. Eur Respir J. 2000, 15: 25-29.PubMedGoogle Scholar
  14. Wahlstrom R, Lagerlov P, Lundborg CS, Veninga CCM, Hummers-Pradier E, Dahlgren LO, Denig P: Variations in general practitioners' views of asthma management in four European countries. Soc Sci Med. 2001, 53: 507-518. 10.1016/S0277-9536(00)00356-7.View ArticlePubMedGoogle Scholar
  15. Calverley PM, Walker P: Chronic obstructive pulmonary disease. Lancet. 2003, 362: 1053-1061. 10.1016/S0140-6736(03)14416-9.View ArticlePubMedGoogle Scholar
  16. Tattersfield AE, Knox AJ, Britton JR, Hall IP: Asthma. Lancet. 2002, 360: 1313-1322. 10.1016/S0140-6736(02)11312-2.View ArticlePubMedGoogle Scholar
  17. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997, 349: 1498-1504. 10.1016/S0140-6736(96)07492-2.View ArticlePubMedGoogle Scholar
  18. G. B, van Schayck CP, van Mollen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, Buitendijk MJ, van Herwaarden CL, van Weel C: Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998, 158: 1730-1738.View ArticleGoogle Scholar
  19. van Schayck CP, Dompeling E, van Herwaarden CL, Folgering H, Verbeek AL, van der Hoogen HJ, van Weel C: Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ. 1991, 303: 1426-1431.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Dompeling E, van Schayck CP, van Grunsven PM, van Herwaarden CL, Akkermans R, Molema J, Folgering H, van Weel C: Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med. 1993, 118: 770-778.View ArticlePubMedGoogle Scholar
  21. van Grunsven P, Schermer T, Akkermans R, Albers M, van den BG, van Schayck O, van Herwaarden C, van Weel C: Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study. Respir Med. 2003, 97: 1303-1312. 10.1016/j.rmed.2003.08.001.View ArticlePubMedGoogle Scholar
  22. Hansell A, Hollowell J, Nichols T, McNiece R, Strachan D: Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax. 1999, 54: 413-419.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Himmel W, Hummers-Pradier E, Schumann H, Kochen MM: The predictive value of asthma medications to identify individuals with asthma-a study in German general practices. Br J Gen Pract. 2001, 51: 879-883.PubMedPubMed CentralGoogle Scholar
  24. Okkes IM, Lambers H: Classification and the domain of family practice. Oxford Textbook of Primary Medical Care, Volume 1. Edited by: Jones R, Britten R, Culpepper L, Gass D, Grol R, Mant D and Silagy.C . 2004, Oxford, Oxford University Press, 139-153.Google Scholar
  25. Hasselgren M, Arne M, Lindahl A, Janson S, Lundback B: Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care. Scand J Prim Health Care. 2001, 19: 54-57. 10.1080/028134301300034701.View ArticlePubMedGoogle Scholar
  26. Jacobs JE, van de Lisdonk EH, Smeele I, van Weel C, Grol RP: Management of patients with asthma and COPD: monitoring quality of life and the relationship to subsequent GP interventions. Fam Pract. 2001, 18: 574-580. 10.1093/fampra/18.6.574.View ArticlePubMedGoogle Scholar
  27. Soriano JB, Kiri VA, Maier WC, Strachan D: Increasing prevalence of asthma in UK primary care during the 1990s. Int J Tuberc Lung Dis. 2003, 7: 415-421.PubMedGoogle Scholar
  28. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/5/11/prepub

Copyright

© Schneider et al; licensee BioMed Central Ltd. 2005

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.